FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors:#hemophiliab #hemob #hemoA #treatment
#hemophiliab #hemob #hemoA #treatment